News
GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.
Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback